本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

15.79
+0.62004.09%
成交量:119.95万
成交额:1,867.27万
市值:7.86亿
市盈率:-4.27
高:15.85
开:15.32
低:15.09
收:15.17
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

重要事件披露

Form 8-K - Current report
2023/09/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/07/10

重要事件披露

Form 8-K - Current report